What do systematic reviews say?

More intensive vs less intensive insulin therapy

• Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Steroid therapy in first episode of nephrotic syndrome: 3 months or more vs 2 months of therapy

Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: hypertension compared with 2 months of therapy (moderate certainty).

• Corticosteroid therapy for nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 1.78 [0.55, 5.73]
  7 studies · 548 participants
  Moderate

Steroid therapy in first episode of nephrotic syndrome: 3 months or more vs 2 months of therapy

Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: Cushing's syndrome compared with 2 months of therapy (moderate certainty).

• Corticosteroid therapy for nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 1.12 [0.76, 1.65]
  5 studies · 547 participants
  Moderate

Steroid therapy in first episode of nephrotic syndrome: 3 months or more vs 2 months of therapy

Steroid therapy in first episode of nephrotic syndrome: 3 months or… showed no clear difference in adverse events: psychological disorders compared with 2 months of therapy (low certainty).

• Corticosteroid therapy for nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 1 [0.53, 1.9]
  4 studies · 456 participants
  Low